Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126103211 | 12610321 | 1 | I | 20151231 | 0 | 20160729 | 20160729 | DIR | 65.00 | YR | F | N | 155.00000 | LBS | 20160701 | Y | CN | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126103211 | 12610321 | 1 | PS | RECLAST | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | N | D | 0 | |||||||||
| 126103211 | 12610321 | 2 | C | AM-LOAD | 2 | 0 | |||||||||||||
| 126103211 | 12610321 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 4 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 5 | C | GENERAL VITAMINS | 2 | 0 | |||||||||||||
| 126103211 | 12610321 | 6 | C | B VITAMINS | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 7 | C | DULOXETINE. | DULOXETINE | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 9 | C | DICYCLONINE | 2 | 0 | |||||||||||||
| 126103211 | 12610321 | 10 | C | AMOXICILLIN. | AMOXICILLIN | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 11 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 12 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 13 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 14 | C | DICLOFENAC | DICLOFENAC | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 15 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 16 | C | TRIAZOLAM. | TRIAZOLAM | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 17 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 18 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 19 | C | QUETIAPINE. | QUETIAPINE | 1 | 0 | ||||||||||||
| 126103211 | 12610321 | 20 | C | PLAIN VITAMINS | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126103211 | 12610321 | 1 | Bone density decreased |
| 126103211 | 12610321 | 1 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126103211 | 12610321 | OT |
| 126103211 | 12610321 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126103211 | 12610321 | Activities of daily living impaired | |
| 126103211 | 12610321 | Bone pain | |
| 126103211 | 12610321 | Fatigue | |
| 126103211 | 12610321 | Infusion site pain | |
| 126103211 | 12610321 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126103211 | 12610321 | 1 | 20151231 | 20151231 | 0 |